Treatment of Skin Disease-5판

Cover image
Title page
Table of Contents
Copyright
Preface
List of Contributors
Acknowledgments
Dedication
Evidence Levels
Credits
1. Acanthosis nigricans
Management Strategy
2. Acne keloidalis nuchae
Management Strategy
3. Acne vulgaris
Management Strategy
4. Acrodermatitis enteropathica
Management Strategy
5. Actinic keratoses
Management Strategy
6. Actinic prurigo
Management Strategy
7. Actinomycosis
Management Strategy
8. Acute generalized exanthematous pustulosis
Management Strategy
9. Allergic contact dermatitis and photoallergy
Management strategy
10. Alopecia areata
Management Strategy
11. Amyloidosis
Management Strategy
12. Androgenetic alopecia
Management Strategy
13. Angiolymphoid hyperplasia with eosinophilia
Management Strategy
14. Angular cheilitis
Management Strategy
15. Antiphospholipid syndrome
Management Strategy
16. Aphthous stomatitis
Management Strategy
17. Atopic dermatitis
Management Strategy
18. Atypical fibroxanthoma
Management Strategy
19. Atypical nevi
Management Strategy
Specific Investigations
First-Line Therapies
20. Autoimmune progesterone dermatitis
Management Strategy
21. Bacillary angiomatosis
Management Strategy
22. Balanitis
Management Strategy
23. Basal cell carcinoma
Management Strategy
24. Becker nevus
Management Strategy
25. Bed bugs
Management Strategy
26. Behçet disease
Management Strategy
27. Bioterrorism
Smallpox
Management Strategy
Anthrax
Management Strategy
Tularemia
Management Strategy
Plague
Management Strategy
Viral hemorrhagic fevers
Management Strategy
28. Bites and stings
Management Strategy
29. Blastomycosis
Management Strategy
Guidelines
30. Blistering distal dactylitis
Management Strategy
31. Body dysmorphic disorder (dermatologic nondisease)
Management Strategy
32. Bowen disease and erythroplasia of Queyrat
Diagnosis
Management Strategy
33. Bullous pemphigoid
Management Strategy
34. Burning mouth syndrome (glossodynia)
Management Strategy
Specific Investigations
35. Calcinosis cutis
Management Strategy
36. Calciphylaxis
Management Strategy
37. Capillaritis (pigmented purpuric dermatoses)
Management Strategy
38. Cat scratch disease
Management Strategy
39. Cellulite
Management Strategy
40. Cellulitis and erysipelas
Management Strategy
41. Chancroid
Diagnosis and Management Strategy
Special considerations: Evacuation of buboes and unusual manifestations
42. Chilblains
Management Strategy
43. Chondrodermatitis nodularis helicis chronicus
Management Strategy
44. Chromoblastomycosis
Management Strategy
45. Chronic actinic dermatitis
Management Strategy
46. Coccidioidomycosis
Management Strategy
Current Guidelines
47. Confluent and reticulated papillomatosis
Management Strategy
48. Cryopyrin-associated periodic syndromes (CAPS)
Management Strategy
Second-Line Therapy
49. Cryptococcosis
Management Strategy
Third-Line Therapies
Guidelines
50. Cutaneous candidiasis and chronic mucocutaneous candidiasis
Cutaneous candidiasis
Management Strategy
Chronic mucocutaneous candidiasis
Management Strategy
51. Cutaneous larva migrans
Management Strategy
Specific Investigations
52. Cutaneous polyarteritis nodosa
Management Strategy
53. Darier disease
Management Strategy
54. Decubitus ulcers
Management Strategy
55. Delusions of parasitosis
Management Strategy
56. Dermatitis artefacta
Management Strategy
57. Dermatitis herpetiformis
Management Strategy
58. Dermatofibrosarcoma protuberans
Management Strategy
59. Dermatomyositis
Management Strategy
60. Diaper dermatitis
Management Strategy
61. Discoid (Nummular) eczema
Management Strategy
62. Discoid lupus erythematosus
Management Strategy
63. Dissecting cellulitis of the scalp
Management Strategy
64. Drug eruptions
Management Strategy
65. Eosinophilic fasciitis
Management Strategy
66. Epidermal nevi
Management Strategy
Verrucous epidermal nevi
Inflammatory/dysplastic epidermal nevi
67. Epidermodysplasia verruciformis
Management Strategy
68. Epidermolysis bullosa
Management Strategy
69. Epidermolysis bullosa acquisita
Management Strategy
70. Erosive pustular dermatosis
Management Strategy
71. Erythema annulare centrifugum
Management Strategy
72. Erythema dyschromicum perstans
Management Strategy
Therapy
73. Erythema elevatum diutinum
Management Strategy
74. Erythema multiforme
Management Strategy
75. Erythema nodosum
Management Strategies
76. Erythrasma
Management Strategy
77. Erythroderma
Management Strategy
78. Erythrokeratodermas
Management Strategy
79. Erythromelalgia
Management Strategy
80. Erythropoietic protoporphyria
Management Strategy
81. Extramammary Paget disease
Management Strategy
82. Fabry disease
Management Strategy
83. Flushing
Management Strategy
84. Follicular mucinosis
Management Strategy
85. Folliculitis
Management Strategy
86. Folliculitis decalvans
Management Strategy
87. Fox–Fordyce disease
Management Strategy
88. Furunculosis
Management Strategy
89. Condyloma acuminata
Management Strategy
90. Geographic tongue
Management Strategy
91. Gianotti–Crosti syndrome
Management Strategy
92. Gonorrhea
Management Strategy
Special Considerations
93. Graft-versus-host disease
Management Strategy
Acute GVHD
Chronic GVHD
94. Granuloma annulare
Management Strategy
Localized Granuloma Annulare
Generalized (Disseminated) Granuloma Annulare
95. Granuloma faciale
Management Strategy
96. Granuloma inguinale
Management Strategy
Special considerations
97. Granulomatous cheilitis
Management Strategy
98. Hailey–Hailey disease
Management Strategy
99. Hand and foot eczema (endogenous, dyshidrotic eczema, pompholyx)
Management Strategy
100. Hemangiomas
Management Strategy
101. Hereditary angioedema
Management Strategy
Acute Angioedema
Acute Angioedema
Long-Term Prophylaxis of Hereditary Angioedema
Prevention of Relapse Due to Dental and Surgical Interventions
Treatment in Children
Hereditary Angioedema With Normal C1inh
102. Hereditary hemorrhagic telangiectasia
Management Strategy
103. Herpes genitalis
Management Strategy
Novel and Other Therapies
Prevention
104. Herpes labialis
Management Strategy
Other Therapies
105. Herpes zoster
Management Strategy
106. Hidradenitis Suppurativa
Management Strategy
Specific Investigation
107. Histoplasmosis
Management Strategy
108. Hydroa vacciniforme
Management Strategy
109. Hyperhidrosis
Management Strategy
110. Hypertrichosis and hirsutism
Introduction
Management Strategy
111. Hypopigmented disorders
Management Strategy
112. Ichthyoses
Management Strategy
113. Impetigo
Management Strategy
114. Inducible urticarias, aquagenic pruritus, and cholinergic pruritus
Inducible urticarias
Management Strategy
Aquagenic pruritus
Management Strategy
Cholinergic pruritus
Management Strategy
115. Irritant contact dermatitis
Management Strategy
116. Jellyfish stings
Clinical Features
Cutaneous Manifestations Of Jellyfish Stings
Management Strategy
117. Jessner lymphocytic infiltrate
Management Strategy
118. Juvenile plantar dermatosis
Management Strategy
119. Juvenile xanthogranuloma
Management Strategy
120. Kaposi sarcoma
Management Strategy
121. Kawasaki disease
Management Strategies
122. Keloids
Management Strategy
123. Keratoacanthoma
Management Strategy
124. Keratosis pilaris and variants
Management Strategy
125. Langerhans cell histiocytosis
Management Strategy
126. Leg ulcers
Management Strategy
127. Leiomyoma
Management Strategy
128. Leishmaniasis
Management Strategy
129. Lentigo maligna
Management Strategy
130. Leprosy (including reactions)
Management Strategy
131. Leukocytoclastic vasculitis
Management Strategy
132. Lichen myxedematosus
Management Strategy
133. Lichen nitidus
Management Strategy
134. Lichen planopilaris
Management Strategy
135. Lichen planus
Management Strategy
136. Lichen sclerosus
Management Strategy
137. Lichen simplex chronicus
Management Strategy
138. Linear IgA bullous dermatosis
Management Strategy
139. Lipodermatosclerosis
Management Strategy
140. Livedo reticularis
Management Strategy
141. Livedoid vasculopathy
Management Strategy
142. Lyme borreliosis
Management Strategy
Specific Investigations
143. Lymphangioma circumscriptum
Management Strategies
144. Lymphedema
Management Strategies
145. Lymphocytoma cutis
Management Strategy
146. Lymphogranuloma venereum
Management Strategy
147. Lymphomatoid papulosis
Management Strategy
148. Malignant atrophic papulosis
Management Strategy
149. Malignant melanoma
Management Strategy
150. Mastocytoses
Management Strategy
151. Melasma
Management Strategy
152. Merkel cell carcinoma
Management Strategy
153. Methicillin-resistant Staphylococcus aureus and Panton–Valentine leukocidin Staphylococcus aureus
infections
Management Strategy (MRSA)
Specific Investigations
PVL-SA Management Strategy
154. Miliaria
Management Strategy
155. Molluscum contagiosum
Management Strategy
156. Morphea
Management Strategy
157. Mucoceles
Management Strategy
158. Mucous membrane pemphigoid
Management Strategy
159. Mycetoma: Eumycetoma and actinomycetoma
Management Strategy
160. Mycobacterial (atypical) skin infections
Fish Tank (Swimming Pool) Granuloma
Management Strategy
Mycobacterium ulcerans
Management Strategy
Mycobacterium Kansasii
Management Strategy
Rapidly Growing Mycobacteria
Management Strategy
161. Mycosis fungoides and Sézary syndrome
Management Strategy
162. Myiasis
Management Strategy
163. Myxoid cyst
Management Strategy
164. Nail psoriasis
Management Strategy
165. Necrobiosis lipoidica
Management Strategy
166. Necrolytic acral erythema
Management Strategy
167. Necrolytic migratory erythema
Management Strategy
168. Nephrogenic systemic fibrosis
Management Strategy
169. Neurofibromatosis, type 1
Management Strategy
170. Nevoid basal cell carcinoma syndrome
Management Strategy
171. Nevus sebaceus
Management Strategy
172. Notalgia paresthetica
Management Strategy
173. Onchocerciasis
Management Strategy
Other therapies
174. Oral lichen planus
Management Strategy
175. Orf
Management Strategy
176. Palmoplantar keratoderma
Management Strategy
177. Palmoplantar pustulosis
Management Strategy
178. Panniculitis
Management Strategy
Lupus Panniculitis
Nodular Vasculitis
Pancreatic Panniculitis
Cytophagic Histiocytic Panniculitis
α1-Antitrypsin Deficiency Panniculitis
179. Papular urticaria
Management Strategy
180. Paracoccidioidomycosis (South American blastomycosis)
Management Strategy
181. Parapsoriasis
Management Strategy
Small Plaque Parapsoriasis
Large Plaque Parapsoriasis
182. Paronychia
Management Strategy
183. Parvovirus infection
Management Strategy
184. Pediculosis
Pediculosis Capitis
Pediculosis Corporis
Pediculosis Pubis
Phthiriasis Palpebrarum
185. Pemphigus
Management Strategy
186. Perforating dermatoses
Management Strategy
187. Perioral dermatitis
Management Strategy
188. Peutz–Jeghers syndrome
Management Strategy
189. Pinta and yaws
Management Strategy
190. Pitted and ringed keratolysis (keratolysis plantare sulcatum)
Management Strategy
191. Pityriasis rubra pilaris
Management Strategy
192. Pityriasis lichenoides chronica
Management Strategy
193. Pityriasis lichenoides et varioliformis acuta
Management Strategy
194. Pityriasis rosea
Management Strategy
195. Polycystic ovary syndrome
Management Strategy
196. Polymorphic light eruption
Management Strategy
197. Porokeratoses
Management Strategy
198. Porphyria cutanea tarda
Management Strategy
199. Port wine stain (“nevus flammeus”)
Management Strategy
200. Postinflammatory hyperpigmentation and other disorders of hyperpigmentation
Postinflammatory Hyperpigmentation
Freckles
Lentigines
Melasma
Periorbital Hyperpigmentation
Riehl Melanosis
Phototoxic Dermatitis
Erythema Dyschromicum Perstans
Lichen Planus Pigmentosus
Poikioderma of Civatte
Management Strategy
201. Pregnancy dermatoses
Polymorphic Eruption of Pregnancy
Management Strategy
Pemphigoid Gestationis
Management Strategy
Intrahepatic Cholestasis of Pregnancy
Management Strategy
Atopic Eruption of Pregnancy
Management Strategy
202. Pretibial myxedema
Management Strategy
203. Prurigo nodularis
Management Strategy
204. Prurigo pigmentosa
Management Strategy
205. Pruritus
Management Strategy
Neuropathic itch
Cholestatic itch
Itch associated with cholestasis of pregnancy
Renal itch
Itch associated with malignancy
Itch associated with hematologic disorders
Miscellaneous diseases associated with itch
206. Pruritus ani
Management Strategy
207. Pruritus vulvae
Management Strategy
208. Pseudofolliculitis barbae
Management Strategy
209. Pseudoxanthoma elasticum
Management Strategy
210. Psoriasis
Management Strategy
Guttate Psoriasis
Inverse Psoriasis
Impetigo Herpetiformis
Erythrodermic Psoriasis
Pustular Psoriasis
211. Psychogenic excoriation
Management Strategy
212. Pyoderma gangrenosum
Management Strategy
213. Pyogenic granuloma
Management Strategy
214. Radiation dermatitis
Management Strategy
215. Raynaud disease and phenomenon
Management Strategy
216. Reactive arthritis
Management Strategy
217. Regional pain and complex regional pain
Complex Regional Pain Syndrome
Management Strategy
Prevention
218. Relapsing polychondritis
Management Strategy
219. Rhinophyma
Management Strategy
220. Rocky Mountain spotted fever and other rickettsial infections
Rickettsial Spotted Fevers
Management Strategy
Typhus Group
Management Strategy
Rickettsialpox
Management Strategy
Q Fever
Management Strategy
Ehrlichiosis
Management Strategy
221. Rosacea
Management Strategy
Inflammatory rosacea
Erythematotelangiectatic rosacea
Rosacea flushing
Rosacea lymphedema (Morbihan disease)
Ocular rosacea
Rosacea fulminans
222. Sarcoidosis
Management Strategy
223. Scabies
Management Strategy
224. Scleredema
Management Strategy
225. Scleroderma
Management Strategy
Other: Internal Organ Involvement
226. Sebaceous hyperplasia
Management Strategy
227. Seborrheic eczema
Management Strategy
Nonscalp Disease
Scalp Disease
228. Seborrheic keratosis
Management Strategy
229. Sporotrichosis
Management Strategy
Guidelines
230. Squamous cell carcinoma
Management Strategy
231. Staphylococcal scalded skin syndrome
Management Strategy
232. Steatocystoma multiplex
Management Strategy
233. Stoma care
Management Strategy
234. Striae
Management Strategy
235. Subacute cutaneous lupus erythematosus
Management Strategy
236. Subcorneal pustular dermatosis
Management Strategy
237. Subcutaneous fat necrosis of the newborn
Management Strategy
238. Sweet syndrome
Management Strategy
239. Syphilis
Management Strategy
Diagnostics and Treatment
240. Syringomata
Management Strategy
241. Tinea capitis
Management Strategy
242. Tinea pedis and skin dermatophytosis
Management Strategy
243. Tinea unguium
Management Strategy
Topical Therapies
244. Tinea versicolor (pityriasis versicolor)
Management Strategy
245. Toxic epidermal necrolysis and Stevens–Johnson syndrome
Management Strategy
246. Transient acantholytic dermatosis (Grover disease)
Management Strategy
247. Trichotillomania
Diagnosis
Management Strategy
248. Tuberculosis and tuberculids
Management Strategy
249. Urticaria and angioedema
Urticaria
Management Strategy
Angioedema
Management Strategy for Bradykinin-Mediated Angioedema
250. Varicella
Management Strategy
Pregnancy
Prophylaxis
251. Viral exanthems: rubella, roseola, rubeola, and enteroviruses
Rubella
Management Strategy
Roseola
Management Strategy
Rubeola
Management Strategy
Enteroviruses
Management Strategy
252. Viral warts
Management Strategy
253. Vitiligo
Management Strategy
Emerging Treatments
254. Vulvodynia
Management Strategy
255. Wells syndrome
Management Strategy
256. Xanthomas
Management Strategy
257. Xeroderma pigmentosum
Management Strategy
258. Xerosis
Management Strategy
259. Yellow nail syndrome
Management Strategy
Index